BackInterpace Biosciences Overview

Interpace Biosciences Profit Margin

Profitability ratio analysis for IDXG.

Quarterly Profit Margin

7.98%
↓ 44.19% YoY

As of Mar 2026

Annual Profit Margin (TTM)

65.25%
↑ 298.79% YoY

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin